ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA ...

The global cystic fibrosis therapeutics market size is calculated at USD 11.81 billion in 2025 and is expected to reach ...

New research from the Arnold School's Department of Epidemiology and Biostatistics has found disparities in mortality rates ...

Organizers of the University of Manitoba’s edition of the Shinerama fundraiser are pictured recently. The students will be ...

The Cystic Fibrosis Foundation is hosting an event in Arkansas with the ambitious goal of raising between $250,000 and ...

Their research led to the development of a drug that nearly doubles the life expectancy for adult cystic fibrosis patients.

D Molecular Therapeutics (FDMT) offers attractive growth potential with strong cash reserves and promising late-stage gene ...

This Friday, October 3rd, the Cystic Fibrosis Foundation will host its Little Rock Finest event at 6:30 p.m. in Argenta Plaza, bringing together the best of the ...

Michael J. Welsh has won the Lasker Award and the 2025 Canada Gairdner International Award for his contributions to cystic ...

A pair of San Diego scientists who helped develop a treatment for cystic fibrosis, a life-threatening genetic disorder that damages people’s organs, have been named recipients of a 2025 Lasker Award, ...

Washington: Cystic fibrosis was once a dire, likely deadly diagnosis, destroying a patient's ability to breathe and digest food -- but a revolutionary new treatment offers reason for hope. And on ...

Aaron Britton was the long-time camp director at the Wilton YMCA until he was diagnosed with cystic fibrosis in 2016.